2Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem [J]. Br J Ophthalmol,2001,85(11):1277-1282.
3Schuman JS, Horwitz B, Choplin NT, et al. Al-year study of brimonidine twice daily in glaucoma and ocular hypertension [J]. Arch Ophthaimol, 1997,115(7):847-852.
4Orzalesi N, Rossetti L, Bottoli A, et al. Comparison of the effects of la- tanoprost, travoprost and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension [J]. Ophthalmology, 2006,113(2):239-246.
5Parrish RK, Palmberg P, Sheu WP. A comparison of latanoprost, bi- matoprost and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multieenter study [J]. Am J Ophthalmol,2004,137(2):387-388.
6Feiner L, Piltz-Seymour JR. Collaborative initial glaucoma treatment study: a summary of results to date [J]. Curt Opin Ophthalmol,2003,14(2): 106-111.
7Francis BA, Du LT, Berke S, et al. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dor- zolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study [J]. J Clin Pharm Ther,2004,29(4):375-380.
